Laurent et al. develop a liver-targeted gene therapy using recombinant adeno-associated viral vector (rAAV) to effectively cure Lysosomal acid lipase deficiency. This occurs via correction of lipid accumulation and normalized gene expression patterns and mitochondrial function in Lipa−/− mice.
- Marine Laurent
- Rim Harb
- Mario Amendola